CD39 and CD73 expressed on ovarian cancer cells generate adenosine that exerts an immunosuppressive effect, which was relieved by siRNAs against CD39 and CD73 and by an A2A antagonist [444]. This evidence concerns the gene ENTPD1 and ovarian carcinoma.